Advertisement

Click here for more guidelines.





CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:2315-2323, doi:10.1016/j.jacc.2009.02.057
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, P. R.
Right arrow Articles by Fuster, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Moreno, P. R.
Right arrow Articles by Fuster, V.
Related Collections
Right arrowRelated Article

STATE-OF-THE-ART PAPER

Promoting Mechanisms of Vascular Health

Circulating Progenitor Cells, Angiogenesis, and Reverse Cholesterol Transport

Pedro R. Moreno, MD*, Javier Sanz, MD* and Valentin Fuster, MD, PhD*,{dagger},*

* Zena and Michael A. Wiener Cardiovascular Institute, and the Marie-Josee and Henry R. Kravis Cardiovascular Health Center, The Mount Sinai School of Medicine, New York, New York
{dagger} The Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Manuscript received November 14, 2008; revised manuscript received January 27, 2009, accepted February 6, 2009.

* Reprint requests and correspondence: Dr. Valentin Fuster, Mount Sinai School of Medicine, Box 1030, New York, New York 10029 (Email: valentin.fuster{at}mountsinai.org).

To understand and promote vascular health, we must reduce the aggression to the vessel wall and enhance the physiologic mechanisms leading to restoration of vessel wall function. Three main defense mechanisms are responsible for maintaining cardiovascular homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis, and macrophage-mediated reverse cholesterol transport. Endothelial progenitor cells can restore vessel wall function and reduce atherosclerosis. In patients with risk factors, high levels of circulating progenitor cells increase event-free survival from cardiovascular events. Mobilization of progenitor cells includes physical and pharmacological approaches, of which exercise and statin therapy have great potential. Angiogenesis is a pivotal defense mechanism to counteract hypoxia and is needed for plaque regression. However, neovessels are susceptible for intraplaque hemorrhage, particularly in diabetes mellitus. In these patients, the haptoglobin 2-2 genotype is the more affected, and may benefit from an antioxidant approach. Finally, the reverse cholesterol transport system is the main mechanism for plaque regression. In addition to high-density lipoprotein cholesterol, apolipoprotein A-I therapies and the promotion of cholesterol efflux from macrophages by the ABCA1 and ABCG1 transporter systems hold great promise and may be available for therapeutic application in the near future.

Key Words: atherosclerosis • endothelium • angiogenesis • regression

Abbreviations and Acronyms
  ApoA-I = apolipoprotein A-I
  CETP = cholesterol ester transporter protein
  CVD = cardiovascular disease
  EPC = endothelial progenitor cell
  Hb = hemoglobin
  HDL = high-density lipoprotein
  HDL-C = high-density lipoprotein cholesterol
  Hp = haptoglobin


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A28. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Kheirandish-Gozal, R. Bhattacharjee, J. Kim, H. B. Clair, and D. Gozal
Endothelial Progenitor Cells and Vascular Dysfunction in Children with Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., July 1, 2010; 182(1): 92 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 6, 2010; 55(14): 1487 - 1498.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. Sluijs, Y. Plantinga, B. de Roos, L. I Mennen, and M. L Bots
Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults
Am. J. Clinical Nutrition, January 1, 2010; 91(1): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
P. R. Moreno
The High-Risk Thin-Cap Fibroatheroma: A New Kid on the Block
Circ Cardiovasc Interv, December 1, 2009; 2(6): 500 - 502.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement